PATENT CLAIM ANALYSIS

Application Number: 15949509
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["435", "325000"]

Abstract:
The present invention relates to the use of an hydrogel comprising silylated biomolecule for the three-dimensional culture of cardiomyocytes or stem cells which are able to differentiate into cardiomyocytes, and to an aqueous composition comprising i) cardiomyocytes or stem cells which are able to differentiate into cardiomyocytes, and ii) a hydrogel comprising silylated biomolecule, for use for treating heart failure, in particular heart failure following myocardial infarction.

Claim (Index 26):
The method according to  claim 21  wherein the silylated biomolecule is selected from the group consisting of a silylated polysaccharide, a silylated peptide, a silylated protein, and an association of two different biomolecules selected from a silylated polysaccharide, a silylated peptide, and a silylated protein.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 91.0
- Lexical Diversity: 1.7619
- Patent Class: 435.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14123286', '13777139', '12751445', '14127991', '14473521']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6690230669628993
- 35 USC 102 Novelty (BERT): 0.6109362909273143
- Combined Prediction Score: 0.6632143893593407
- Mean Citation Score: 309.78278199999994
- Max Citation Score: 614.4156
- Similarity Product: 481.90616869361406

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test